RAPT Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $127,062,000.
Profit Margin
| 2017 | 0 | -29.11M | |
|---|---|---|---|
| 2018 | 0 | -36.14M | |
| 2019 | 0 | -42.99M | |
| 2020 | 5.04M | -52.89M | -1049.03% |
| 2021 | 3.81M | -68.20M | -1788.83% |
| 2022 | 1.52M | -81.88M | -5362.21% |
| 2023 | 0 | -116.79M |
RAPT Income Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 0 | 1.52M | 3.81M | 5.04M | 0 | 0 | 0 |
Cost of revenue | 3.55M | 2.80M | 996K | 0 | 1.33M | 0 | 1.38M |
Gross profit | -3.55M | -1.28M | 2.81M | 5.04M | -1.33M | 0 | -1.38M |
Operating exp. | |||||||
Research and development | 101.00M | 67.08M | 56.98M | 45.48M | 34.91M | 31.76M | 25.61M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 127.06M | 87.32M | 73.02M | 58.25M | 43.62M | 36.94M | 29.33M |
Operating income | -127.06M | -85.79M | -69.20M | -53.21M | -43.62M | -36.94M | -29.33M |
Other income (expenses), net | 10.26M | 1.95M | 5K | 1.31M | 1.29M | 800K | 216K |
Income before tax | -116.79M | -83.83M | -69.20M | -51.90M | -42.33M | -36.14M | -29.11M |
Income tax expense | 0 | -1.95M | -996K | 990K | 660K | 800K | 0 |
Net income | -116.79M | -81.88M | -68.20M | -52.89M | -42.99M | -36.14M | -29.11M |
Earnings per share | |||||||
Basic EPS | -3.05 | -2.52 | -2.49 | -2.19 | -1.97 | -2.09 | -2.01 |
Diluted EPS | -3.05 | -2.52 | -2.49 | -2.19 | -1.97 | -2.09 | -2.01 |
| Data source | Data source | Data source | Data source | Data source |